메뉴 건너뛰기




Volumn 6, Issue 4, 2012, Pages 288-295

An invisible threat: Mutation-mediated resistance to triazole drugs in aspergillus

Author keywords

Aspergillus; Aspergillus fumigatus; Cyp51a; Itraconazole; Posaconazole; Resistance; Triazole; Voriconazole

Indexed keywords

TRIAZOLE;

EID: 84880732715     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-012-0106-x     Document Type: Article
Times cited : (4)

References (83)
  • 1
    • 70349646099 scopus 로고    scopus 로고
    • Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network
    • 19692558 10.1128/JCM.00854-09 1:CAS:528:DC%2BD1MXhsVeru77E This study investigated the susceptibility of various clinically relevant Aspergillus spp. in transplants recipients
    • • Baddley JW, Marr KA, Andes DR, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47(10):3271-5. This study investigated the susceptibility of various clinically relevant Aspergillus spp. in transplants recipients.
    • (2009) J Clin Microbiol , vol.47 , Issue.10 , pp. 3271-3275
    • Baddley, J.W.1    Marr, K.A.2    Andes, D.R.3
  • 2
    • 78149265758 scopus 로고    scopus 로고
    • In vitro susceptibility testing of Aspergillus spp. Against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin
    • 21034656 1:CAS:528:DC%2BC3cXhsFWgsrvM
    • Shi J-Y, Xu Y-C, Shi Y, et al. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin. Chin Med J. 2010;123(19):2706-9.
    • (2010) Chin Med J , vol.123 , Issue.19 , pp. 2706-2709
    • Shi, J.-Y.1    Xu, Y.-C.2    Shi, Y.3
  • 3
    • 77951954182 scopus 로고    scopus 로고
    • Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air
    • 20193715 10.1016/j.mimet.2010.02.012 1:CAS:528:DC%2BC3cXkvFKlt7g%3D
    • Vanhee LM, Perman D, Nelis HJ, et al. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air. J Microbiol Methods. 2010;81(2):197-9.
    • (2010) J Microbiol Methods , vol.81 , Issue.2 , pp. 197-199
    • Vanhee, L.M.1    Perman, D.2    Nelis, H.J.3
  • 4
    • 33846867922 scopus 로고    scopus 로고
    • Filamentous fungi in a tertiary care hospital: Environmental surveillance and susceptibility to antifungal drugs
    • 17230389 10.1086/508832
    • Panagopoulou P, Filioti J, Farmeki E, et al. Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs. Infect Control Hosp Epidemiol. 2007;28(1):60-7.
    • (2007) Infect Control Hosp Epidemiol , vol.28 , Issue.1 , pp. 60-67
    • Panagopoulou, P.1    Filioti, J.2    Farmeki, E.3
  • 5
    • 77950682818 scopus 로고    scopus 로고
    • Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study
    • 19850903 10.3324/haematol.2009.012054
    • Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95(4):644-50.
    • (2010) Haematologica , vol.95 , Issue.4 , pp. 644-650
    • Pagano, L.1    Caira, M.2    Candoni, A.3
  • 6
    • 37849001095 scopus 로고    scopus 로고
    • Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
    • 17906086 10.1183/09031936.00062206 1:STN:280:DC%2BD2srotlKiug%3D%3D
    • Bulpa P, Dive A, Sebille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30(4):782-800.
    • (2007) Eur Respir J , vol.30 , Issue.4 , pp. 782-800
    • Bulpa, P.1    Dive, A.2    Sebille, Y.3
  • 7
    • 80052800770 scopus 로고    scopus 로고
    • Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States
    • 20557463 10.1111/j.1439-0507.2010.01903.x
    • Kim A, Nicolau DP, Kuti JL. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses. 2011;54(5):e301-12.
    • (2011) Mycoses , vol.54 , Issue.5
    • Kim, A.1    Nicolau, D.P.2    Kuti, J.L.3
  • 8
    • 84870753321 scopus 로고    scopus 로고
    • Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
    • doi: 10.3109/13693786.2012.690108
    • Baddley JW, Andes DR, Marr KA, et al. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol. 2012. doi: 10.3109/13693786.2012.690108.
    • (2012) Med Mycol
    • Baddley, J.W.1    Andes, D.R.2    Marr, K.A.3
  • 9
    • 77950278696 scopus 로고    scopus 로고
    • Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
    • 20218876 10.1086/651262 This paper highlights the prevalence of invasive aspergillosis in organ transplant recipients
    • • Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101-11. This paper highlights the prevalence of invasive aspergillosis in organ transplant recipients.
    • (2010) Clin Infect Dis , vol.50 , Issue.8 , pp. 1101-1111
    • Pappas, P.G.1    Alexander, B.D.2    Andes, D.R.3
  • 10
    • 77950280868 scopus 로고    scopus 로고
    • Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) Database
    • 20218877 10.1086/651263 This paper highlights the prevalence of invasive aspergillosis in HSTC transplant recipients
    • • Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091-100. This paper highlights the prevalence of invasive aspergillosis in HSTC transplant recipients.
    • (2010) Clin Infect Dis , vol.50 , Issue.8 , pp. 1091-1100
    • Kontoyiannis, D.P.1    Marr, K.A.2    Park, B.J.3
  • 11
    • 77952237526 scopus 로고    scopus 로고
    • Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: A review of 43 cases
    • 19910234 10.1016/j.ijid.2009.07.011
    • Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis. 2010;14(6):e479-82.
    • (2010) Int J Infect Dis , vol.14 , Issue.6
    • Nam, H.S.1    Jeon, K.2    Um, S.W.3
  • 12
    • 84863925051 scopus 로고    scopus 로고
    • Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: Population pharmacokinetics-based analysis of adult patients with invasive fungal infections
    • 22610925 10.1093/cid/cis437 1:CAS:528:DC%2BC38XhtVeju77F
    • Pascual A, Csajka C, Buclin T, et al. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis. 2012;55(3):381-90.
    • (2012) Clin Infect Dis , vol.55 , Issue.3 , pp. 381-390
    • Pascual, A.1    Csajka, C.2    Buclin, T.3
  • 13
    • 77957241722 scopus 로고    scopus 로고
    • Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
    • 20729241 10.1093/jac/dkq279 1:CAS:528:DC%2BC3cXhtFylsb3J This paper highlights the frequency of Aspergillus infections and antifungal resistance in UK from 1997 to 2009
    • • Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother. 2010;65(10):2116-8. This paper highlights the frequency of Aspergillus infections and antifungal resistance in UK from 1997 to 2009.
    • (2010) J Antimicrob Chemother , vol.65 , Issue.10 , pp. 2116-2118
    • Bueid, A.1    Howard, S.J.2    Moore, C.B.3
  • 14
    • 80051827318 scopus 로고    scopus 로고
    • Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene
    • 21690285 10.1128/AAC.00185-11 1:CAS:528:DC%2BC3MXhtFaitr3I This paper highlights the global frequency of antifungal resistance using the ARTEMIS collection. More importantly, this is the first paper that reported the TR34/L98H resistance mechanism in A. fumigatus outside Europe
    • • Lockhart SR, Frade JP, Etienne KA, et al. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother. 2011;55(9):4465-8. This paper highlights the global frequency of antifungal resistance using the ARTEMIS collection. More importantly, this is the first paper that reported the TR34/L98H resistance mechanism in A. fumigatus outside Europe.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.9 , pp. 4465-4468
    • Lockhart, S.R.1    Frade, J.P.2    Etienne, K.A.3
  • 15
    • 84930481483 scopus 로고    scopus 로고
    • Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009
    • 22000354 10.3201/eid1710.110226
    • van der Linden JW, Snelders E, Kampinga GA, et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis. 2011;17(10):1846-54.
    • (2011) Emerg Infect Dis , vol.17 , Issue.10 , pp. 1846-1854
    • Van Der Linden, J.W.1    Snelders, E.2    Kampinga, G.A.3
  • 16
    • 79953702873 scopus 로고    scopus 로고
    • Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
    • 20595150 10.1183/09031936.00054810 1:STN:280:DC%2BC3MzotFymsQ%3D%3D
    • Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2011;37:865-72.
    • (2011) Eur Respir J , vol.37 , pp. 865-872
    • Smith, N.L.1    Denning, D.W.2
  • 17
    • 0042243672 scopus 로고    scopus 로고
    • Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
    • 12689933 10.1182/blood-2003-02-0456 1:CAS:528:DC%2BD3sXlvFCmsLs%3D
    • Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827-33.
    • (2003) Blood , vol.102 , pp. 827-833
    • Fukuda, T.1    Boeckh, M.2    Carter, R.A.3
  • 18
    • 84886723436 scopus 로고    scopus 로고
    • Cystic Fibrosis Canada Accessed 7 Sept 2012
    • Cystic Fibrosis Canada. Canadian CF Patient Data Registry Report - 2010. http://www.cysticfibrosis.ca/assets/files/pdf/CPDR-ReportE.pdf. Accessed 7 Sept 2012.
    • Canadian CF Patient Data Registry Report 2010
  • 19
    • 82555161638 scopus 로고    scopus 로고
    • Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
    • 22271943 10.2471/BLT.11.089441
    • Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Org. 2011;89:864-72.
    • (2011) Bull World Health Org , vol.89 , pp. 864-872
    • Denning, D.W.1    Pleuvry, A.2    Cole, D.C.3
  • 20
    • 12944291020 scopus 로고    scopus 로고
    • Aspergillus infections in transplant recipients
    • 15653818 10.1128/CMR.18.1.44-69.2005 1:CAS:528:DC%2BD2MXhs1Oms70%3D
    • Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.
    • (2005) Clin Microbiol Rev , vol.18 , Issue.1 , pp. 44-69
    • Singh, N.1    Paterson, D.L.2
  • 21
    • 84860484915 scopus 로고    scopus 로고
    • The airway microbiota in cystic fibrosis: A complex fungal and bacterial community-implications for therapeutic management
    • 22558432 10.1371/journal.pone.0036313 1:CAS:528:DC%2BC38Xnt1Cru74%3D
    • Delhaes L, Monchy S, Fréalle E, et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS One. 2012;7(4):e36313.
    • (2012) PLoS One , vol.7 , Issue.4 , pp. 36313
    • Delhaes, L.1    Monchy, S.2    Fréalle, E.3
  • 22
    • 84858697840 scopus 로고    scopus 로고
    • Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: A case control study from China
    • 22023558 10.1111/j.1469-0691.2011.03503.x 1:STN:280: DC%2BC38zmsl2mtA%3D%3D
    • Xu H, Li L, Wang LX, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect. 2012;18(4):403-8.
    • (2012) Clin Microbiol Infect , vol.18 , Issue.4 , pp. 403-408
    • Xu, H.1    Li, L.2    Wang, L.X.3
  • 23
    • 78249285274 scopus 로고    scopus 로고
    • The nationwide Austrian Aspergillus registry: A prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
    • 20947312 10.1016/j.ijantimicag.2010.08.010 1:CAS:528:DC%2BC3cXhsVagur3M
    • Perkhofer S, Lass-Flörl C, Hell M, et al. The nationwide Austrian Aspergillus registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents. 2010;36(6):531-6.
    • (2010) Int J Antimicrob Agents , vol.36 , Issue.6 , pp. 531-536
    • Perkhofer, S.1    Lass-Flörl, C.2    Hell, M.3
  • 24
    • 58749083534 scopus 로고    scopus 로고
    • Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry
    • 19115967 10.1086/595846 1:CAS:528:DC%2BD1MXivVSlsLY%3D
    • Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009;48(3):265-73.
    • (2009) Clin Infect Dis , vol.48 , Issue.3 , pp. 265-273
    • Neofytos, D.1    Horn, D.2    Anaissie, E.3
  • 25
    • 80052590640 scopus 로고    scopus 로고
    • Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole
    • 21314250
    • Michallet M, Sobh M, Morisset S, et al. Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Med Mycol. 2011;49(7):681-7.
    • (2011) Med Mycol , vol.49 , Issue.7 , pp. 681-687
    • Michallet, M.1    Sobh, M.2    Morisset, S.3
  • 26
    • 84863842038 scopus 로고    scopus 로고
    • Invasive aspergillosis: An important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
    • 21909650 10.1007/s10096-011-1397-5 1:STN:280:DC%2BC38zlslWhug%3D%3D
    • Michallet M, Bénet T, Sobh M, et al. Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis. 2012;31(6):991-7.
    • (2012) Eur J Clin Microbiol Infect Dis , vol.31 , Issue.6 , pp. 991-997
    • Michallet, M.1    Bénet, T.2    Sobh, M.3
  • 27
    • 35348882622 scopus 로고    scopus 로고
    • Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne
    • 17918077 10.1086/522189 1:STN:280:DC%2BD2srpsFylsQ%3D%3D
    • Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis. 2007;45(9):1161-70.
    • (2007) Clin Infect Dis , vol.45 , Issue.9 , pp. 1161-1170
    • Pagano, L.1    Caira, M.2    Nosari, A.3
  • 28
    • 84859365677 scopus 로고    scopus 로고
    • Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation
    • Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.
    • (2011) OPTN/SRTR 2010 Annual Data Report
  • 30
    • 0036278959 scopus 로고    scopus 로고
    • Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7
    • 12115841 10.1002/jps.10126 1:CAS:528:DC%2BD38XktlWrsrc%3D
    • Peeters J, Neeskens P, Tollenaere JP, et al. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. J Pharm Sci. 2002;91(6):1414-22.
    • (2002) J Pharm Sci , vol.91 , Issue.6 , pp. 1414-1422
    • Peeters, J.1    Neeskens, P.2    Tollenaere, J.P.3
  • 32
    • 79961170502 scopus 로고    scopus 로고
    • The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: A retrospective analysis
    • 21512792 10.1007/s15010-011-0108-6 1:CAS:528:DC%2BC3MXoslaqsLo%3D
    • Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011;39(3):201-10.
    • (2011) Infection , vol.39 , Issue.3 , pp. 201-210
    • Schwartz, S.1    Reisman, A.2    Troke, P.F.3
  • 33
    • 84886727212 scopus 로고    scopus 로고
    • European Committee on Antimicrobial Susceptibility Testing Accessed 7 Sept 2012
    • European Committee on Antimicrobial Susceptibility Testing. Rationale documents on antifungal agents. http://www.eucast.org/antifungal-susceptibility- testing-afst/rationale-documents-for-antifungals/. Accessed 7 Sept 2012.
    • Rationale Documents on Antifungal Agents
  • 35
    • 70349640159 scopus 로고    scopus 로고
    • Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods
    • 19692559 10.1128/JCM.00940-09 1:CAS:528:DC%2BD1MXhsVerurfI
    • Pfaller MA, Diekema DJ, Ghannoum MA, et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol. 2009;47(10):3142-6.
    • (2009) J Clin Microbiol , vol.47 , Issue.10 , pp. 3142-3146
    • Pfaller, M.A.1    Diekema, D.J.2    Ghannoum, M.A.3
  • 36
    • 78650054144 scopus 로고    scopus 로고
    • In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test
    • 20557462 10.1111/j.1439-0507.2010.01913.x 1:STN:280: DC%2BC3MfivVyksA%3D%3D
    • Kondori N, Svensson E, Mattsby-Baltzer I. In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test. Mycoses. 2011;54(5):e318-22.
    • (2011) Mycoses , vol.54 , Issue.5
    • Kondori, N.1    Svensson, E.2    Mattsby-Baltzer, I.3
  • 37
    • 77956796313 scopus 로고    scopus 로고
    • Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)
    • 20592159 10.1128/JCM.00536-10 1:CAS:528:DC%2BC3cXhsVKqt7%2FJ This paper established the ECV for Aspergillus spp. and thus serve as a guideline for researchers to determine resistant aspergilli
    • •• Espinel-Ingroff A, Diekema DJ, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol. 2010;48(9):3251-7. This paper established the ECV for Aspergillus spp. and thus serve as a guideline for researchers to determine resistant aspergilli.
    • (2010) J Clin Microbiol , vol.48 , Issue.9 , pp. 3251-3257
    • Espinel-Ingroff, A.1    Diekema, D.J.2    Fothergill, A.3
  • 38
    • 0037043655 scopus 로고    scopus 로고
    • Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    • 12167683 10.1056/NEJMoa020191 1:CAS:528:DC%2BD38XlvFKrt7o%3D
    • Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-15.
    • (2002) N Engl J Med , vol.347 , Issue.6 , pp. 408-415
    • Herbrecht, R.1    Denning, D.W.2    Patterson, T.F.3
  • 39
    • 39449095735 scopus 로고    scopus 로고
    • Treatment of aspergillosis: Clinical practice guidelines of the Infectious Disease Society of America
    • 18177225 10.1086/525258 1:CAS:528:DC%2BD1cXitlKqt7c%3D
    • Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis. 2008;46:327-60.
    • (2008) Clin Infect Dis , vol.46 , pp. 327-360
    • Walsh, T.J.1    Anaissie, E.J.2    Denning, D.W.3
  • 40
    • 84863774640 scopus 로고    scopus 로고
    • Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis
    • 22676861 10.1016/j.diagmicrobio.2012.05.001
    • Neofytos D, Shoham S, Dierberg K, et al. Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis. Diagn Microbiol Infect Dis. 2012;73(4):374-5.
    • (2012) Diagn Microbiol Infect Dis , vol.73 , Issue.4 , pp. 374-375
    • Neofytos, D.1    Shoham, S.2    Dierberg, K.3
  • 41
    • 84865372882 scopus 로고    scopus 로고
    • Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study
    • 22653819 10.1093/jac/dks189 1:CAS:528:DC%2BC38Xht1egt7rM
    • Auberger J, Lass-Flörl C, Aigner M, et al. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 2012;67(9):2268-73.
    • (2012) J Antimicrob Chemother , vol.67 , Issue.9 , pp. 2268-2273
    • Auberger, J.1    Lass-Flörl, C.2    Aigner, M.3
  • 42
    • 77958609698 scopus 로고    scopus 로고
    • Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation
    • 10.1016/j.transproceed.2010.08.013
    • Paniagua MM, Marzoa R, Barge CE, et al. Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation. Transplant Proc. 2010;42(8):3014-6.
    • (2010) Transplant Proc , vol.42 , Issue.8 , pp. 3014-3016
    • Paniagua, M.M.1    Marzoa, R.2    Barge, C.E.3
  • 43
    • 77953936585 scopus 로고    scopus 로고
    • Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis
    • 19673966 10.1111/j.1469-0691.2009.02911.x 1:CAS:528:DC%2BC3cXot1GmsLo%3D
    • Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect. 2010;16:683-8.
    • (2010) Clin Microbiol Infect , vol.16 , pp. 683-688
    • Howard, S.J.1    Pasqualotto, A.C.2    Denning, D.W.3
  • 44
    • 84857792588 scopus 로고    scopus 로고
    • Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia
    • 21779887 10.1007/s15010-011-0158-9
    • Björkholm M, Kalin M, Grane B, et al. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia. Infection. 2012;40(1):81-5.
    • (2012) Infection , vol.40 , Issue.1 , pp. 81-85
    • Björkholm, M.1    Kalin, M.2    Grane, B.3
  • 45
    • 84860724509 scopus 로고    scopus 로고
    • Orbital aspergillosis: Voriconazole - The new standard treatment?
    • 10.1159/000336276
    • Ohlstein DH, Hooten C, Perez J, et al. Orbital aspergillosis: voriconazole - the new standard treatment? Case Rep Ophthalmol. 2012;3(1):46-53.
    • (2012) Case Rep Ophthalmol , vol.3 , Issue.1 , pp. 46-53
    • Ohlstein, D.H.1    Hooten, C.2    Perez, J.3
  • 46
    • 84857757180 scopus 로고    scopus 로고
    • Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus
    • 22396740 10.1371/journal.pone.0031801 1:CAS:528:DC%2BC38Xjs12rs78%3D This study investigated the impact that fungicides might have on TR34/L98H mutation. It suggests that this resistance mechanism is mediated by fungicides
    • •• Snelders E, Camps SM, Karawajczyk A, et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One. 2012;7(3):e31801. This study investigated the impact that fungicides might have on TR34/L98H mutation. It suggests that this resistance mechanism is mediated by fungicides.
    • (2012) PLoS One , vol.7 , Issue.3 , pp. 31801
    • Snelders, E.1    Camps, S.M.2    Karawajczyk, A.3
  • 47
    • 67650657544 scopus 로고    scopus 로고
    • Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure
    • 19624922 10.3201/eid1507.090043 1:CAS:528:DC%2BD1MXptFGhs7w%3D
    • Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009;15(7):1068-76.
    • (2009) Emerg Infect Dis , vol.15 , Issue.7 , pp. 1068-1076
    • Howard, S.J.1    Cerar, D.2    Anderson, M.J.3
  • 48
    • 70749088981 scopus 로고    scopus 로고
    • Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
    • 19879181 10.1016/j.drup.2009.09.002 1:CAS:528:DC%2BD1MXhsFagtLrF
    • Verweij PE, Howard SJ, Melchers WJ, et al. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat. 2009;12(6):141-7.
    • (2009) Drug Resist Updat , vol.12 , Issue.6 , pp. 141-147
    • Verweij, P.E.1    Howard, S.J.2    Melchers, W.J.3
  • 49
    • 84855860621 scopus 로고    scopus 로고
    • Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India
    • 22028200 10.1093/jac/dkr443 1:CAS:528:DC%2BC38XoslSjtw%3D%3D This study showed that the TR34/L98H resistance mechanism is present in India
    • • Chowdhary A, Kathuria S, Randhawa HS, et al. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother. 2012;67(2):362-6. This study showed that the TR34/L98H resistance mechanism is present in India.
    • (2012) J Antimicrob Chemother , vol.67 , Issue.2 , pp. 362-366
    • Chowdhary, A.1    Kathuria, S.2    Randhawa, H.S.3
  • 50
    • 84455170016 scopus 로고    scopus 로고
    • Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan
    • 22024829 10.1128/AAC.05394-11 1:CAS:528:DC%2BC38Xjt1KgsA%3D%3D
    • Tashiro M, Izumikawa K, Minematsu A, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother. 2012;56(1):584-7.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.1 , pp. 584-587
    • Tashiro, M.1    Izumikawa, K.2    Minematsu, A.3
  • 51
    • 78049318458 scopus 로고    scopus 로고
    • Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain
    • 20805399 10.1128/AAC.00692-10 1:CAS:528:DC%2BC3cXhsVCitr7F This study suggested that the TR34/L98H resistance mechanism has an environmental origin
    • • Mortensen KL, Mellado E, Lass-Flörl C, et al. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother. 2010;54(11):4545-9. This study suggested that the TR34/L98H resistance mechanism has an environmental origin.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.11 , pp. 4545-4549
    • Mortensen, K.L.1    Mellado, E.2    Lass-Flörl, C.3
  • 52
    • 79953306496 scopus 로고    scopus 로고
    • Azole resistance in Aspergillus fumigatus: A new challenge in the management of invasive aspergillosis?
    • 21449843 10.2217/fmb.11.4 1:CAS:528:DC%2BC3MXktVCmtrk%3D
    • Snelders E, Melchers WJ, Verweij PE. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? Future Microbiol. 2011;6(3):335-47.
    • (2011) Future Microbiol , vol.6 , Issue.3 , pp. 335-347
    • Snelders, E.1    Melchers, W.J.2    Verweij, P.E.3
  • 53
    • 79955789192 scopus 로고    scopus 로고
    • Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - Review of the literature
    • 10.1186/2047-783X-16-4-153
    • Mayr A, Lass-Flörl C. Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature. Eur J Med Res. 2011;13:153-7.
    • (2011) Eur J Med Res , vol.13 , pp. 153-157
    • Mayr, A.1    Lass-Flörl, C.2
  • 54
    • 84871622723 scopus 로고    scopus 로고
    • In vitro and in vivo role of heat shock protein 90 in amphotericin B resistance of Aspergillus terreus
    • doi: 10.1111/j.1469-0691.2012.03848.x
    • Blum G, Kainzner B, Grif K, et al. In vitro and in vivo role of heat shock protein 90 in amphotericin B resistance of Aspergillus terreus. Clin Microbiol Infect. 2012 doi: 10.1111/j.1469-0691.2012.03848.x.
    • (2012) Clin Microbiol Infect
    • Blum, G.1    Kainzner, B.2    Grif, K.3
  • 55
    • 84867554258 scopus 로고    scopus 로고
    • Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection
    • doi: 10.3109/13693786.2012.684154
    • Hadrich I, Makni F, Neji S, et al. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012. doi: 10.3109/13693786.2012.684154.
    • (2012) Med Mycol
    • Hadrich, I.1    Makni, F.2    Neji, S.3
  • 56
    • 79960295010 scopus 로고    scopus 로고
    • In vitro echinocandins susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network
    • 21670187 10.1128/AAC.00428-11 1:CAS:528:DC%2BC3MXpslGgurk%3D
    • Lockhart SR, Zimbeck AJ, Baddley JW, et al. In vitro echinocandins susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother. 2011;55(8):3944-6.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.8 , pp. 3944-3946
    • Lockhart, S.R.1    Zimbeck, A.J.2    Baddley, J.W.3
  • 57
    • 84862909219 scopus 로고    scopus 로고
    • Structure complex of sterol-demethylase (CYP51) with 14a- methylenecyclopropyl-d7-24,25-dihydrolanosterol
    • 22135275 10.1194/jlr.M021865 1:CAS:528:DC%2BC38XpvFyhuw%3D%3D
    • Hargrove TY, Wawrzak Z, Liu J, et al. Structure complex of sterol-demethylase (CYP51) with 14a-methylenecyclopropyl-d7-24,25- dihydrolanosterol. J Lipid Res. 2012;53(2):311-20.
    • (2012) J Lipid Res , vol.53 , Issue.2 , pp. 311-320
    • Hargrove, T.Y.1    Wawrzak, Z.2    Liu, J.3
  • 58
    • 77957342347 scopus 로고    scopus 로고
    • Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B
    • 20660663 10.1128/AAC.00316-10 1:CAS:528:DC%2BC3cXhtlegtr%2FP
    • Warrilow AG, Melo N, Martel CM, et al. Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B. Antimicrob Agents Chemother. 2010;54(10):4225-34.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.10 , pp. 4225-4234
    • Warrilow, A.G.1    Melo, N.2    Martel, C.M.3
  • 59
    • 34047236515 scopus 로고    scopus 로고
    • Essential gene identification and drug target prioritization in Aspergillus fumigatus
    • 17352532 10.1371/journal.ppat.0030024
    • Hu W, Sillaots S, Lemieux S, et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 2007;3(3):e24.
    • (2007) PLoS Pathog , vol.3 , Issue.3 , pp. 24
    • Hu, W.1    Sillaots, S.2    Lemieux, S.3
  • 60
    • 13244298189 scopus 로고    scopus 로고
    • Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma
    • 15563516 10.1093/jac/dkh507 1:CAS:528:DC%2BD2MXkt1ajsQ%3D%3D
    • Chen J, Li H, Li R, et al. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005;55(1):31-7.
    • (2005) J Antimicrob Chemother , vol.55 , Issue.1 , pp. 31-37
    • Chen, J.1    Li, H.2    Li, R.3
  • 61
    • 3042531281 scopus 로고    scopus 로고
    • Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs
    • 15215142 10.1128/AAC.48.7.2747-2750.2004 1:CAS:528:DC%2BD2cXlsFWmu7g%3D
    • Mellado E, Garcia-Effron G, Alcazer-Fuoli L, et al. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004;48(7):2747-50.
    • (2004) Antimicrob Agents Chemother , vol.48 , Issue.7 , pp. 2747-2750
    • Mellado, E.1    Garcia-Effron, G.2    Alcazer-Fuoli, L.3
  • 62
    • 77952597776 scopus 로고    scopus 로고
    • Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling
    • 20385860 10.1128/AAC.01599-09 1:CAS:528:DC%2BC3cXos1OhurY%3D
    • Snelders E, Karawajczyk A, Schaftenaar G, et al. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother. 2010;54(6):2425-30.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.6 , pp. 2425-2430
    • Snelders, E.1    Karawajczyk, A.2    Schaftenaar, G.3
  • 63
    • 84455170146 scopus 로고    scopus 로고
    • Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature
    • 22005994 10.1128/AAC.05088-11 1:CAS:528:DC%2BC38Xjt1GmtQ%3D%3D This study demonstrated the ability of A. fumigatus to become resistant to triazoles under drug pressure
    • •• Camps SMT, Camps SMT, van der Linden JW, Li Y, et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother. 2012;56(1):10-6. This study demonstrated the ability of A. fumigatus to become resistant to triazoles under drug pressure.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.1 , pp. 10-16
    • Camps, S.M.T.1    Camps, S.M.T.2    Van Der Linden, J.W.3    Li, Y.4
  • 64
    • 74949099143 scopus 로고    scopus 로고
    • Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma
    • 20055745 10.3109/13693780902717018 1:CAS:528:DC%2BC3cXit1Oisg%3D%3D
    • Bellete B, Raberin H, Morel J, et al. Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Med Mycol. 2010;48(1):197-200.
    • (2010) Med Mycol , vol.48 , Issue.1 , pp. 197-200
    • Bellete, B.1    Raberin, H.2    Morel, J.3
  • 65
    • 84862726659 scopus 로고    scopus 로고
    • Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis
    • 22573589 10.1128/JCM.00329-12 1:CAS:528:DC%2BC38XhtFCmsLnJ
    • Pelaez T, Gijón P, Bunsow E, et al. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis. J Clin Microbiol. 2012;50(7):2531-4.
    • (2012) J Clin Microbiol , vol.50 , Issue.7 , pp. 2531-2534
    • Pelaez, T.1    Gijón, P.2    Bunsow, E.3
  • 66
    • 80054697382 scopus 로고    scopus 로고
    • Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter
    • 21876055 10.1128/AAC.00517-11 1:CAS:528:DC%2BC3MXhsVSru7jE
    • Albarrag AM, Anderson MJ, Howard SJ, et al. Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother. 2011;55(11):5113-21.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.11 , pp. 5113-5121
    • Albarrag, A.M.1    Anderson, M.J.2    Howard, S.J.3
  • 67
    • 84862606349 scopus 로고    scopus 로고
    • In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration
    • 22782947 10.1093/infdis/jis442 1:CAS:528:DC%2BC38XhtlWltbfE
    • Arendrup MC, Jensen RH, Grif K, et al. In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration. J Infect Dis. 2012;206(6):981-5.
    • (2012) J Infect Dis , vol.206 , Issue.6 , pp. 981-985
    • Arendrup, M.C.1    Jensen, R.H.2    Grif, K.3
  • 68
    • 84860197333 scopus 로고    scopus 로고
    • The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis
    • 22314539 10.1128/AAC.05477-11 1:CAS:528:DC%2BC38XmsVKrsb8%3D
    • Liu W, Sun Y, Chen W, et al. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis. Antimicrob Agents Chemother. 2012;56(5):2598-603.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.5 , pp. 2598-2603
    • Liu, W.1    Sun, Y.2    Chen, W.3
  • 69
    • 55249114346 scopus 로고    scopus 로고
    • Molecular characterisation of cyp51A and cyp51B genes coding for P450 14α-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus
    • 18775650 10.1016/j.ijantimicag.2008.06.018 1:CAS:528:DC%2BD1cXhtlGls7zO
    • Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, et al. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14α-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 2008;32(6):519-24.
    • (2008) Int J Antimicrob Agents , vol.32 , Issue.6 , pp. 519-524
    • Krishnan-Natesan, S.1    Chandrasekar, P.H.2    Alangaden, G.J.3
  • 70
    • 84865422021 scopus 로고    scopus 로고
    • Azole preexposure affects the Aspergillus fumigatus population in patients
    • 22710122 10.1128/AAC.05990-11 1:CAS:528:DC%2BC38Xht12mtL7N
    • Alanio A, Cabaret O, Sitterlé E, et al. Azole preexposure affects the Aspergillus fumigatus population in patients. Antimicrob Agents Chemother. 2012;56(9):4948-50.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.9 , pp. 4948-4950
    • Alanio, A.1    Cabaret, O.2    Sitterlé, E.3
  • 71
    • 7244243917 scopus 로고    scopus 로고
    • In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance
    • 15504870 10.1128/AAC.48.11.4405-4413.2004
    • da Silva Ferreira ME, Capellaro JL, dos Res Marques E, et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother. 2004;48(11):4405-13.
    • (2004) Antimicrob Agents Chemother , vol.48 , Issue.11 , pp. 4405-4413
    • Da Silva Ferreira, M.E.1    Capellaro, J.L.2    Dos Res Marques, E.3
  • 72
    • 34047269418 scopus 로고    scopus 로고
    • Multiple-triazole-resistant aspergillosis
    • 17409336 10.1056/NEJMc061720 1:CAS:528:DC%2BD2sXjslyntb4%3D
    • Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med. 2007;356(14):1481-3.
    • (2007) N Engl J Med , vol.356 , Issue.14 , pp. 1481-1483
    • Verweij, P.E.1    Mellado, E.2    Melchers, W.J.3
  • 73
    • 56749159784 scopus 로고    scopus 로고
    • Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism
    • 18998768 10.1371/journal.pmed.0050219
    • Snelders E, van der Lee HA, Kuijpers J, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5(11):e219.
    • (2008) PLoS Med , vol.5 , Issue.11 , pp. 219
    • Snelders, E.1    Van Der Lee, H.A.2    Kuijpers, J.3
  • 74
    • 34250223076 scopus 로고    scopus 로고
    • A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations
    • 17371828 10.1128/AAC.01092-06 1:CAS:528:DC%2BD2sXmtlKku7s%3D
    • Mellado E, Garcia-Effron G, Alcazer-Fuoli L, et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother. 2007;51(6):1897-904.
    • (2007) Antimicrob Agents Chemother , vol.51 , Issue.6 , pp. 1897-1904
    • Mellado, E.1    Garcia-Effron, G.2    Alcazer-Fuoli, L.3
  • 75
    • 77956302523 scopus 로고    scopus 로고
    • Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence
    • 20404915 10.1371/journal.pone.0010080
    • Arendrup MC, Mavridou E, Mortensen KL, et al. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One. 2010;5(4):e10080.
    • (2010) PLoS One , vol.5 , Issue.4 , pp. 10080
    • Arendrup, M.C.1    Mavridou, E.2    Mortensen, K.L.3
  • 76
    • 79953869925 scopus 로고    scopus 로고
    • High-frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease
    • 21467016 10.1093/cid/cir179 1:CAS:528:DC%2BC3MXksFGktbw%3D This study showed that the rate of triazole resistance aspergilli might be underreported. It also indicated that TR34 and L98H might exist as single mutation in patients
    • • Denning DW, Park S, Lass-Flörl C, et al. High-frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52(9):1123-9. This study showed that the rate of triazole resistance aspergilli might be underreported. It also indicated that TR34 and L98H might exist as single mutation in patients.
    • (2011) Clin Infect Dis , vol.52 , Issue.9 , pp. 1123-1129
    • Denning, D.W.1    Park, S.2    Lass-Flörl, C.3
  • 77
    • 84864401552 scopus 로고    scopus 로고
    • Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism
    • 22675126 10.1128/JCM.00335-12 This study demonstrated that TR34/L98H mutants are closely related genetically. The study also implied that this mutation might originate from a single ancestor/location and spread to different places around the world
    • •• Camps SM, Rijs AJ, Klaassen CH, et al. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism. J Clin Microbiol. 2012;50(8):2674-80. This study demonstrated that TR34/L98H mutants are closely related genetically. The study also implied that this mutation might originate from a single ancestor/location and spread to different places around the world.
    • (2012) J Clin Microbiol , vol.50 , Issue.8 , pp. 2674-2680
    • Camps, S.M.1    Rijs, A.J.2    Klaassen, C.H.3
  • 78
    • 84856074224 scopus 로고    scopus 로고
    • High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole
    • 22123701 10.1128/AAC.05077-11 1:CAS:528:DC%2BC38Xhs1Grtb8%3D
    • Burgel PR, Baixench MT, Amsellem M, et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother. 2012;56(2):869-74.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.2 , pp. 869-874
    • Burgel, P.R.1    Baixench, M.T.2    Amsellem, M.3
  • 79
    • 84864526497 scopus 로고    scopus 로고
    • High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis
    • 22581906 10.1093/jac/dks160 1:CAS:528:DC%2BC38XhtVeisbrM
    • Morio F, Aubin GG, Danner-Boucher I, et al. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. J Antimicrob Chemother. 2012;67(8):1870-3.
    • (2012) J Antimicrob Chemother , vol.67 , Issue.8 , pp. 1870-1873
    • Morio, F.1    Aubin, G.G.2    Danner-Boucher, I.3
  • 80
    • 79957438194 scopus 로고    scopus 로고
    • Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: A laboratory-based study with focus on Aspergillus fumigatus azole resistance
    • 10.1128/JCM.00213-11
    • Mortensen KL, Jensen RH, Johansen HK, et al. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J Clin Microbiol. 2010;49(6):2243-51.
    • (2010) J Clin Microbiol , vol.49 , Issue.6 , pp. 2243-2251
    • Mortensen, K.L.1    Jensen, R.H.2    Johansen, H.K.3
  • 81
    • 67149128129 scopus 로고    scopus 로고
    • Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles
    • 19376899 10.1128/AEM.00231-09 1:CAS:528:DC%2BD1MXotFalsLw%3D
    • Snelders E, Huis In 't Veld RA, Rijs AJ, et al. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol. 2009;75(12):4053-407.
    • (2009) Appl Environ Microbiol , vol.75 , Issue.12 , pp. 4053-4407
    • Snelders, E.1    Huis In Veld 'T, R.A.2    Rijs, A.J.3
  • 82
    • 0036346165 scopus 로고    scopus 로고
    • Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate
    • 12135575 10.1016/S1087-1845(02)00016-6 1:CAS:528:DC%2BD38XlsFKhs7w%3D
    • Slaven JW, Anderson MJ, Sanglard D, et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol. 2002;36(3):199-206.
    • (2002) Fungal Genet Biol , vol.36 , Issue.3 , pp. 199-206
    • Slaven, J.W.1    Anderson, M.J.2    Sanglard, D.3
  • 83
    • 84862241442 scopus 로고    scopus 로고
    • Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus
    • 22509997 10.1111/j.1574-6968.2012.02575.x 1:CAS:528:DC%2BC38XovFalsrs%3D
    • Bowyer P, Mosquera J, Anderson M, et al. Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus. FEMS Microbiol Lett. 2012;332(1):10-9.
    • (2012) FEMS Microbiol Lett , vol.332 , Issue.1 , pp. 10-19
    • Bowyer, P.1    Mosquera, J.2    Anderson, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.